Open AccessAbstract CT218: Flat-dose nivolumab (NIVO) as second-line (2L) treatment (tx) for Asian patients (pts) with advanced non-small cell lung cancer (NSCLC): CheckMate 870
Author(s) -
Shun Lu,
Ying Cheng,
Jianying Zhou,
Mengzhao Wang,
Jun Zhao,
Gongyan Chen,
Baocheng Wang,
Jifeng Feng,
Zhiyong Ma,
Lin Wu,
Changli Wang,
Shucai Zhang,
Kewei Ma,
Jun Liang,
Yong Song,
Jie Wang,
YiLong Wu,
Ang Li,
Tianzhou Ma,
Jianhua Chang
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct218
Subject(s) - medicine , nivolumab , dosing , adverse effect , gastroenterology , lung cancer , hepatitis b virus , oncology , cancer , immunology , immunotherapy , virus